SlideShare a Scribd company logo

Product Quality Review.pptx

Product Quality Review (PQR) in Pharmaceutical Industry. Oral dosage forms.

1 of 16
Download to read offline
Product Quality Reviews (PQRs)
PQR
 Product Quality Review (PQR) is a mechanism to ensure that data captured by the
Pharmaceutical Quality System (PQS) is reviewed for trends.
 Regular periodic or rolling quality reviews of all authorised medicinal products,
including export only products, should be conducted with the objective of verifying the
consistency of the existing process, the appropriateness of current specifications for
both starting materials and finished product, to highlight any trends and to identify
product and process improvements.
Objective of a PQR are:
 Verify the consistency of the existing manufacturing process
 Verify the appropriateness of current specifications for both starting materials and
finished products
 Highlight any adverse quality trends
 Identify product and process improvements
PQRs provide:
 Useful information and additional controls over manufacturing processes and quality
requirements
 Important information for release for supply (RFS) authorised persons
Implementation of PQR outcomes
 The data generated and evaluated in the PQR should be used to identify any items for
continuous quality improvements and an action plan should be documented to manage
this process.
Manufacturer Responsibilities
 Prepare the data for the PQR related to their manufacturing steps
 List significant non-conformances, deviations and CAPAs for equipment, process and
products
 Submit data and lists to the PQR compiler
 Retain a copy of the data and lists, for provision to TGA inspectors
 Hold objective evidence that demonstrates that responsibilities have been undertaken
Ad

Recommended

More Related Content

What's hot

production planning
 production planning production planning
production planningPRANJAY PATIL
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of AuditMegha bhise
 
Gmp c gmp presentation
Gmp c gmp presentationGmp c gmp presentation
Gmp c gmp presentationDeepak Amoli
 
GMP and cGMP
GMP and cGMPGMP and cGMP
GMP and cGMPGaurav Kr
 
01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentationKathey Bacigalupo
 
Process validation of drug product
Process validation of drug productProcess validation of drug product
Process validation of drug productsantoshnarla
 
c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)Rohit K.
 
Auditing in pharmacutical industries
Auditing in pharmacutical industriesAuditing in pharmacutical industries
Auditing in pharmacutical industriesPriyanka Kandhare
 
BP 606T Lecture 1
BP 606T Lecture 1BP 606T Lecture 1
BP 606T Lecture 1D2 SIR
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. AmsavelDr. Amsavel A
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-recordsDr. Ray Ziai
 
Good manufacturing practices (GMP)
Good manufacturing practices (GMP)Good manufacturing practices (GMP)
Good manufacturing practices (GMP)Priyanka Sapkal
 

What's hot (20)

production planning
 production planning production planning
production planning
 
Introduction to GMP Training by
Introduction to GMP Training byIntroduction to GMP Training by
Introduction to GMP Training by
 
GMP
GMPGMP
GMP
 
Process Validation for Beginners - FDA - EMA Approach
Process Validation for Beginners - FDA - EMA ApproachProcess Validation for Beginners - FDA - EMA Approach
Process Validation for Beginners - FDA - EMA Approach
 
GMP
GMPGMP
GMP
 
GMP compliances of Audit
GMP compliances of AuditGMP compliances of Audit
GMP compliances of Audit
 
Gmp c gmp presentation
Gmp c gmp presentationGmp c gmp presentation
Gmp c gmp presentation
 
GMP and cGMP
GMP and cGMPGMP and cGMP
GMP and cGMP
 
TQM GMP
TQM GMPTQM GMP
TQM GMP
 
01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation01252014 Cvc c gmp presentation
01252014 Cvc c gmp presentation
 
Process validation of drug product
Process validation of drug productProcess validation of drug product
Process validation of drug product
 
GMP Introduction
GMP IntroductionGMP Introduction
GMP Introduction
 
c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)
 
Auditing in pharmacutical industries
Auditing in pharmacutical industriesAuditing in pharmacutical industries
Auditing in pharmacutical industries
 
BP 606T Lecture 1
BP 606T Lecture 1BP 606T Lecture 1
BP 606T Lecture 1
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
 
Review of-batch-production-records
Review of-batch-production-recordsReview of-batch-production-records
Review of-batch-production-records
 
GMP Training
GMP TrainingGMP Training
GMP Training
 
Good manufacturing practices (GMP)
Good manufacturing practices (GMP)Good manufacturing practices (GMP)
Good manufacturing practices (GMP)
 
Umer al faisal
Umer al faisalUmer al faisal
Umer al faisal
 

Similar to Product Quality Review.pptx

GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR trainingAmsavel Vel
 
QA Audit by Signorina Y. Bueno (WMSU-ZC)
QA Audit by Signorina Y. Bueno (WMSU-ZC)QA Audit by Signorina Y. Bueno (WMSU-ZC)
QA Audit by Signorina Y. Bueno (WMSU-ZC)signorina bueno
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singhRanjeet Singh
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Sanathoiba Singha
 
Quality management system
Quality management systemQuality management system
Quality management systemDoaa Abouzeid
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptxAbhishekJadhav189260
 
Pharmacovigilance role through investigating Out of Specification (OOS) for F...
Pharmacovigilance role through investigating Out of Specification (OOS) for F...Pharmacovigilance role through investigating Out of Specification (OOS) for F...
Pharmacovigilance role through investigating Out of Specification (OOS) for F...Mohamed Raouf
 
Pharmaceutical validation.pptx
Pharmaceutical validation.pptxPharmaceutical validation.pptx
Pharmaceutical validation.pptxArpithaNandakumar1
 
Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)RushikeshPalkar1
 
Validation of equipment copy
Validation of equipment   copyValidation of equipment   copy
Validation of equipment copysneha chavan
 
documentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxdocumentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxashokgorja8
 
documentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxdocumentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxashokgorja8
 

Similar to Product Quality Review.pptx (20)

GMP- APQR Training
GMP- APQR TrainingGMP- APQR Training
GMP- APQR Training
 
GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR training
 
Apr and PQR
Apr and PQRApr and PQR
Apr and PQR
 
Process validation
Process validationProcess validation
Process validation
 
QA Audit by Signorina Y. Bueno (WMSU-ZC)
QA Audit by Signorina Y. Bueno (WMSU-ZC)QA Audit by Signorina Y. Bueno (WMSU-ZC)
QA Audit by Signorina Y. Bueno (WMSU-ZC)
 
Hệ thống quản lý chất lượng JGMP - GMP Nhật Bản
Hệ thống quản lý chất lượng JGMP - GMP Nhật BảnHệ thống quản lý chất lượng JGMP - GMP Nhật Bản
Hệ thống quản lý chất lượng JGMP - GMP Nhật Bản
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singh
 
Vallidation
VallidationVallidation
Vallidation
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation'
 
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile PharmaceuticalsWho Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile Pharmaceuticals
 
PHARMACEUTICAL VALIADATION
PHARMACEUTICAL VALIADATIONPHARMACEUTICAL VALIADATION
PHARMACEUTICAL VALIADATION
 
Quality management system
Quality management systemQuality management system
Quality management system
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptx
 
Pharmacovigilance role through investigating Out of Specification (OOS) for F...
Pharmacovigilance role through investigating Out of Specification (OOS) for F...Pharmacovigilance role through investigating Out of Specification (OOS) for F...
Pharmacovigilance role through investigating Out of Specification (OOS) for F...
 
Pharmaceutical validation.pptx
Pharmaceutical validation.pptxPharmaceutical validation.pptx
Pharmaceutical validation.pptx
 
Validation (1).pptx
Validation (1).pptxValidation (1).pptx
Validation (1).pptx
 
Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)
 
Validation of equipment copy
Validation of equipment   copyValidation of equipment   copy
Validation of equipment copy
 
documentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxdocumentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptx
 
documentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptxdocumentation in pharmaceutical industry ppt.pptx
documentation in pharmaceutical industry ppt.pptx
 

Recently uploaded

Present and Future Requisites for Prosperity in the Caribbean
Present and Future Requisites for Prosperity in the CaribbeanPresent and Future Requisites for Prosperity in the Caribbean
Present and Future Requisites for Prosperity in the CaribbeanCaribbean Development Bank
 
AWS RDS Data API and CloudTrail. Who drop the table_.pdf
AWS RDS Data API and CloudTrail. Who drop the table_.pdfAWS RDS Data API and CloudTrail. Who drop the table_.pdf
AWS RDS Data API and CloudTrail. Who drop the table_.pdfVladimir Samoylov
 
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptx
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptxONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptx
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptxDivyaPatel621561
 
Space expansion: cultural considerations, long term perspectives, and spiritu...
Space expansion: cultural considerations, long term perspectives, and spiritu...Space expansion: cultural considerations, long term perspectives, and spiritu...
Space expansion: cultural considerations, long term perspectives, and spiritu...Giulio Prisco
 
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptxNinia
 
Supporting Resilient Prosperity in the Caribbean
Supporting Resilient Prosperity in the CaribbeanSupporting Resilient Prosperity in the Caribbean
Supporting Resilient Prosperity in the CaribbeanCaribbean Development Bank
 
Chapter 20 Firms in IGCSE economics presentation
Chapter 20  Firms in IGCSE  economics presentationChapter 20  Firms in IGCSE  economics presentation
Chapter 20 Firms in IGCSE economics presentationSamandarbekNumonov
 
KKrish - DOVE Leadership Program Concept
KKrish - DOVE Leadership Program ConceptKKrish - DOVE Leadership Program Concept
KKrish - DOVE Leadership Program ConceptKarthik Krishna
 
VAWC-RA-9262 Anti Violence Against Women and THeir Children
VAWC-RA-9262 Anti Violence Against Women and THeir ChildrenVAWC-RA-9262 Anti Violence Against Women and THeir Children
VAWC-RA-9262 Anti Violence Against Women and THeir Childrendilgpitogo2023
 
DAY 05 Book of Revelation 2-18-24 PPT.pptx
DAY 05 Book of Revelation 2-18-24 PPT.pptxDAY 05 Book of Revelation 2-18-24 PPT.pptx
DAY 05 Book of Revelation 2-18-24 PPT.pptxFamilyWorshipCenterD
 
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptx
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptxTeams Nation 2024 - #Copilot & Teams or Just Premium.pptx
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptxKai Stenberg
 
Partnerships for Resilient Prosperity in the Caribbean
Partnerships for Resilient Prosperity in the CaribbeanPartnerships for Resilient Prosperity in the Caribbean
Partnerships for Resilient Prosperity in the CaribbeanCaribbean Development Bank
 
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdf
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdfInstructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdf
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdfaytenfsuc
 

Recently uploaded (14)

Present and Future Requisites for Prosperity in the Caribbean
Present and Future Requisites for Prosperity in the CaribbeanPresent and Future Requisites for Prosperity in the Caribbean
Present and Future Requisites for Prosperity in the Caribbean
 
AWS RDS Data API and CloudTrail. Who drop the table_.pdf
AWS RDS Data API and CloudTrail. Who drop the table_.pdfAWS RDS Data API and CloudTrail. Who drop the table_.pdf
AWS RDS Data API and CloudTrail. Who drop the table_.pdf
 
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptx
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptxONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptx
ONLINE RESORT BOOKING SYSTEM WEBSITE 1.pptx
 
Space expansion: cultural considerations, long term perspectives, and spiritu...
Space expansion: cultural considerations, long term perspectives, and spiritu...Space expansion: cultural considerations, long term perspectives, and spiritu...
Space expansion: cultural considerations, long term perspectives, and spiritu...
 
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx
1.2 Ingredients Used for Sandwiches 1.3 Culinary Terms.pptx
 
Supporting Resilient Prosperity in the Caribbean
Supporting Resilient Prosperity in the CaribbeanSupporting Resilient Prosperity in the Caribbean
Supporting Resilient Prosperity in the Caribbean
 
Chapter 20 Firms in IGCSE economics presentation
Chapter 20  Firms in IGCSE  economics presentationChapter 20  Firms in IGCSE  economics presentation
Chapter 20 Firms in IGCSE economics presentation
 
KKrish - DOVE Leadership Program Concept
KKrish - DOVE Leadership Program ConceptKKrish - DOVE Leadership Program Concept
KKrish - DOVE Leadership Program Concept
 
VAWC-RA-9262 Anti Violence Against Women and THeir Children
VAWC-RA-9262 Anti Violence Against Women and THeir ChildrenVAWC-RA-9262 Anti Violence Against Women and THeir Children
VAWC-RA-9262 Anti Violence Against Women and THeir Children
 
DAY 05 Book of Revelation 2-18-24 PPT.pptx
DAY 05 Book of Revelation 2-18-24 PPT.pptxDAY 05 Book of Revelation 2-18-24 PPT.pptx
DAY 05 Book of Revelation 2-18-24 PPT.pptx
 
Auditorium Session 1 - Connection - Inclusion
Auditorium Session 1 - Connection - InclusionAuditorium Session 1 - Connection - Inclusion
Auditorium Session 1 - Connection - Inclusion
 
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptx
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptxTeams Nation 2024 - #Copilot & Teams or Just Premium.pptx
Teams Nation 2024 - #Copilot & Teams or Just Premium.pptx
 
Partnerships for Resilient Prosperity in the Caribbean
Partnerships for Resilient Prosperity in the CaribbeanPartnerships for Resilient Prosperity in the Caribbean
Partnerships for Resilient Prosperity in the Caribbean
 
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdf
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdfInstructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdf
Instructional Supervision - By Dr. Cherinet Aytenfsu Weldearegay.pdf
 

Product Quality Review.pptx

  • 2. PQR  Product Quality Review (PQR) is a mechanism to ensure that data captured by the Pharmaceutical Quality System (PQS) is reviewed for trends.  Regular periodic or rolling quality reviews of all authorised medicinal products, including export only products, should be conducted with the objective of verifying the consistency of the existing process, the appropriateness of current specifications for both starting materials and finished product, to highlight any trends and to identify product and process improvements.
  • 3. Objective of a PQR are:  Verify the consistency of the existing manufacturing process  Verify the appropriateness of current specifications for both starting materials and finished products  Highlight any adverse quality trends  Identify product and process improvements
  • 4. PQRs provide:  Useful information and additional controls over manufacturing processes and quality requirements  Important information for release for supply (RFS) authorised persons
  • 5. Implementation of PQR outcomes  The data generated and evaluated in the PQR should be used to identify any items for continuous quality improvements and an action plan should be documented to manage this process.
  • 6. Manufacturer Responsibilities  Prepare the data for the PQR related to their manufacturing steps  List significant non-conformances, deviations and CAPAs for equipment, process and products  Submit data and lists to the PQR compiler  Retain a copy of the data and lists, for provision to TGA inspectors  Hold objective evidence that demonstrates that responsibilities have been undertaken
  • 7. Frequency of PQRs  PQRs are normally conducted and documented annually.  Where a small (statistically invalid) number of batches of a product have been manufactured in the year: • a review can be conducted every 2 years • products may be grouped with other similar products • products may be included in the review using the ‘by exception’ option
  • 8. Content of a PQR The review should: • Capture product quality events • Investigate and thoroughly document any potential impacts on the process or systems as a whole • Be intended to result in continuous product improvement
  • 9. PQR should include at least: (i) A review of starting materials including packaging materials used in the product, especially those from new sources and in particular the review of supply chain traceability of active substances; (ii) A review of critical in-process controls and finished product results; (iii) A review of all batches that failed to meet established specification(s) and their investigation; (iv) A review of all significant deviations or non-conformances, their related investigations, and the effectiveness of resultant corrective and preventive actions taken; (v) A review of all changes carried out to the processes or analytical methods; (vi) A review of Marketing Authorisation variations submitted, granted or refused, including those for third country (export only) dossiers; (vii) A review of the results of the stability monitoring programme and any adverse trends; (viii) A review of all quality-related returns, complaints and recalls and the investigations performed at the time; (ix) A review of adequacy of any other previous product process or equipment corrective actions; (x) For new Marketing Authorisations and variations to Marketing Authorisations, a review of post-marketing commitments; (xi) The qualification status of relevant equipment and utilities, e.g. HVAC, water, compressed gases, etc; (xii) A review of any contractual arrangements as defined in Chapter 7 to ensure that they are up to date.
  • 10. Producing PQRs There are three pathways available to produce PQRs. 1. Product-specific pathway 2. Product grouping pathway 3. Review by exception pathway
  • 11. 1. Product-specific pathway • A product-specific PQR for all batches manufactured during the review period • A report for each product The product-specific pathway is available for any medicinal product. 2. Product grouping pathway • Grouping of products is when one PQR is prepared for a group of products. The grouping process should be appropriate for conducting a PQR and reporting cannot be based on a representative product. • Prepare a scientific justification for how you group products for PQRs. This justification will be assessed for the acceptability of grouping products for PQRs during TGA inspections.
  • 12. Grouping for any medicines Grouping (sometimes referred to as bracketing or matrixing) can be acceptable for any medicinal product when the number of batches manufactured annually for each product within the group is low and the grouped medicines are both: • of the same pharmaceutical form containing the same or very similar active ingredients • manufactured using the same equipment For listed and complementary medicines, grouping can be based on products that have similarly constructed formulations and a similar method of manufacture. The PQR for a group should: • document the grouping approach, with a scientific justification for the approach • include a documented review of all applicable items specified in the Product Quality Review section of PIC/S Guide to GMP • be performed on all batches of a specific group of products manufactured during the review period
  • 13. 3. Review by exception pathway  The PQR by exception is a holistic interrogation of the PQS and quality related events as they relate to the twelve specified items in the Product Quality Review  The aim of the PQR is to identify adverse, out-of-trend or unusual events that indicate potential quality vulnerabilities.  Review by exception is a review of PQS adverse trends in each of the twelve specified items that captures all batches of all products manufactured in the review period. • Adverse trends can be mapped back to identify products or product groups potentially impacted. • The design of the PQR report should highlight any adverse trends detected during the review. A report by exception may be generated to cover: – all products – a group of products – a client’s products – each specific product
  • 14. Aspects of PQS to consider when conducting a PQR by exception 1. A review of starting materials including packaging materials used in the product, especially those from new sources 2. A review of critical in-process controls and finished product results 3. A review of all batches that failed to meet established specification(s) and their investigation 4. A review of all significant deviations or non-conformances, their related investigations, and the effectiveness of resultant corrective and preventative actions taken 5. A review of all changes carried out to the processes or analytical methods 6. A review of marketing authorisation variations submitted, granted or refused
  • 15. 7. A review of the results of the stability monitoring program and any adverse trends 8. A review of all quality-related returns, complaints and recalls and the investigations performed at the time 9. A review of adequacy of any other previous product process or equipment corrective actions 10. For new marketing authorisations and variations to marketing authorisations, a review of post-marketing commitments 11. The qualification status of relevant equipment and utilities, e.g. HVAC, water, compressed gases, etc. 12. A review of any contractual arrangements as defined in Chapter 7 of the PIC/S Guide to ensure that they are up-to-date
  • 16. References  Product Quality Reviews (PQRs) for listed and complementary medicines, Version 2.0, January 2019  TGA-Health safety regulation, Product Quality Review section of Chapter 1, Part 1 of the PIC/S Guide to GMP). -KARISHMA K. MAJIK